[Anti-tumor activity of KRN7000, an alpha-galactosylceramide and its action mechanism].
Kobayashi
E
E
Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Takasaki, Japan. ekobayashi@kirin.co.jp
Koezuka
Y
Y
D000818:Animals; D017951:Antigen Presentation; D018949:Antigens, CD1 / Q000276:immunology; D055610:Antigens, CD1d; D000970:Antineoplastic Agents; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology; D015195:Drug Design; D005699:Galactosylceramides / Q000494:pharmacology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D013329:Structure-Activity Relationship
D018949:Antigens, CD1; D055610:Antigens, CD1d; D000970:Antineoplastic Agents; C526877:CD1D protein, human; D016207:Cytokines; D005699:Galactosylceramides; C103873:KRN 7000